Standard assays underestimate the prevalence of albuminuria
Jim Casey
This article has no abstract so we have provided the first paragraph of the full text.
Microalbuminuria is a risk factor for renal and cardiovascular disease and premature death. It has recently been shown that, compared with high-performance liquid chromatography (HPLC), which detects a fraction of albumin that is not immunoreactive, the standard immunochemical assay underestimates the amount of albumin in the urine of people with diabetes.
Full text of this article is available with one of the following:
- Membership of the International Society of Nephrology. If already a member, please login. If not please join the Society now
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please login for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or login above.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
